 |
|
|
| |
Effect of Ketoconazole on the Pharmacokinetics of Doravirine (MK-1439), a Novel Non-Nucleoside Reverse Transcriptase Inhibitor for the Treatment of HIV-1 Infection
|
| |
| |
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV
& Hepatitis Therapy (IWCPHIVHT) - May 26-28, 2015 Washington, DC, USA
Matt S Anderson,1 Chris Chung,1 Ernestina Tetteh,1 Ka Lai Yee,1 Ying Guo,1
Li Fan,1 Scott Rasmussen,2 John A Wagner,1 Joan R Butterton1
1Merck & Co., Inc., Kenilworth, NJ, USA; 2Celerion, Lincoln, NE, USA
|
| |
|
|
|
|
|
